Internal Medicine, Cardiovascular Disease · New Haven, CT
NPI
1376805622
Since 2012
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
789 Howard Ave
New Haven, CT, 06519
Phone (203) 785-6484
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
1,118 services
Medicare patients, 2024
502
Average age 76
Drug cost, 2024
$11.9M
2,830 prescriptions
Company payments, 2025
$58K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cesia Maria Gallegos Kattan was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 137 times for 103 patients. In total Cesia Maria Gallegos Kattan billed 1,118 services in 38 codes, and Medicare paid $61K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 137 | 103 | $13.04 | $1,787 |
| 78452 Myocardial Perfusion Scan | Office | 112 | 112 | $64.44 | $7,217 |
| 99215 Office E&M - Established | Office | 74 | 59 | $139.75 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 69 | 47 | $13.25 | $914 |
| 93000 Electrocardiogram | Office | 65 | 59 | $11.31 | $735 |
| 93010 Electrocardiogram | Office | 60 | 60 | $6.47 | $388 |
| 99214 Office E&M - Established | Office | 58 | 51 | $98.59 | $5,718 |
| 93018 Electrocardiogram | Facility | 51 | 51 | $10.53 | $537 |
| 99233 Hospital E&M - Subsequent | Facility | 47 | 23 | $95.71 | $4,498 |
| 78452 Myocardial Perfusion Scan | Facility | 46 | 46 | $58.23 | $2,679 |
| 99215 Office E&M - Established | Facility | 45 | 35 | $116.56 | $5,245 |
| 93018 Electrocardiogram | Office | 40 | 40 | $9.76 | $390 |
| 78431 Myocardial Perfusion Scan | Facility | 40 | 40 | $67.15 | $2,686 |
| 78434 Myocardial Perfusion Scan | Facility | 40 | 40 | $22.57 | $903 |
| 99232 Hospital E&M - Subsequent | Facility | 35 | 15 | $63.61 | $2,226 |
By year: 2022 $46K for 686 services; 2023 $51K for 799 services; 2024 $61K for 1,118 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cesia Maria Gallegos Kattan prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 401 prescriptions and refills. In total Cesia Maria Gallegos Kattan wrote 2,830 Medicare prescriptions that cost $11.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyndamax Tafamidis | 401 | 507 | 53 | $11.2M |
| Metoprolol Succinate Generic | 231 | 677 | 73 | $2,536 |
| Rosuvastatin Calcium Generic | 220 | 604 | 73 | $2,794 |
| Spironolactone Generic | 220 | 601 | 72 | $2,091 |
| Atorvastatin Calcium Generic | 210 | 564 | 72 | $2,537 |
| Furosemide Generic | 179 | 463 | 65 | $792 |
| Jardiance Empagliflozin | 153 | 367 | 49 | $213K |
| Lisinopril Generic | 96 | 275 | 32 | $618 |
| Losartan Potassium Generic | 90 | 257 | 30 | $531 |
| Ezetimibe Generic | 88 | 246 | 29 | $1,372 |
| Eliquis Apixaban | 81 | 205 | 34 | $120K |
| Amlodipine Besylate Generic | 76 | 189 | 24 | $372 |
| Farxiga Dapagliflozin Propanediol | 72 | 176 | 24 | $100K |
| Carvedilol Generic | 67 | 201 | 27 | $433 |
| Entresto Sacubitril/Valsartan | 59 | 129 | 19 | $85K |
Brand drugs: 935 claims; generic drugs: 1,895 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cesia Maria Gallegos Kattan $58K ($58K in general payments such as food, travel and fees) from 5 companies. The largest payer was Novo Nordisk AS with $22K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.